Keith T. LePage

758 total citations
17 papers, 613 citations indexed

About

Keith T. LePage is a scholar working on Molecular Biology, Environmental Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Keith T. LePage has authored 17 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Environmental Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Keith T. LePage's work include Marine Toxins and Detection Methods (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Ion channel regulation and function (4 papers). Keith T. LePage is often cited by papers focused on Marine Toxins and Detection Methods (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Ion channel regulation and function (4 papers). Keith T. LePage collaborates with scholars based in United States, Canada and Singapore. Keith T. LePage's co-authors include Thomas F. Murray, William H. Gerwick, Robert Dickey, Edward L.E. Jester, Frederick W. Berman, Daniel G. Baden, Douglas E. Goeger, Robert L. Taylor, W. Elwood Briles and S.E. Bloom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Keith T. LePage

17 papers receiving 599 citations

Peers

Countries citing papers authored by Keith T. LePage

Since Specialization

Citations

This map shows the geographic impact of Keith T. LePage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith T. LePage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith T. LePage more than expected).

Fields of papers citing papers by Keith T. LePage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith T. LePage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith T. LePage. The network helps show where Keith T. LePage may publish in the future.

Co-authorship network of co-authors of Keith T. LePage

This figure shows the co-authorship network connecting the top 25 collaborators of Keith T. LePage. A scholar is included among the top collaborators of Keith T. LePage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith T. LePage. Keith T. LePage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Investigation of cancer cell lines for peptide receptor-targeted drug development 2011 ·Journal of drug targeting ·Lichun Sun, (unknown), (unknown), Lynsie Morris, (unknown), Keith T. LePage, David H. Coy	14
2	Involvement of Caspase Activation in Azaspiracid-Induced Neurotoxicity in Neocortical Neurons 2010 ·Toxicological Sciences ·Zhengyu Cao, Keith T. LePage, Michael O. Frederick, Kyriacos C. Nicolaou, Thomas F. Murray	35
3	Application of human pancreatic carcinoid BON cells for receptor-targeted drug development 2010 ·Journal of drug targeting ·Lichun Sun, Lynsie Morris, (unknown), (unknown), Juliana Leslie, (unknown), Joseph A. Fuselier, Keith T. LePage, David H. Coy	3
4	Gambierol Acts as a Functional Antagonist of Neurotoxin Site 5 on Voltage-Gated Sodium Channels in Cerebellar Granule Neurons 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Keith T. LePage, Jon D. Rainier, Henry W. B. Johnson, Daniel G. Baden, Thomas F. Murray	37
5	Cloning and characterization of genes encoding α and β subunits of glutamate-gated chloride channel protein in Cylicocyclus nassatus 2006 ·Molecular and Biochemical Parasitology ·Ritesh Tandon, Keith T. LePage, Ray M. Kaplan	21
6	The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons 2005 ·Toxicology Letters ·Keith T. LePage, Douglas E. Goeger, Fumiaki Yokokawa, (unknown), Takayuki Shioiri, William H. Gerwick, Thomas F. Murray	47
7	Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors 2005 ·Neuropharmacology ·Keith T. LePage, J. Ishmael, (unknown), Stephen F. Traynelis, Thomas F. Murray	35
8	On the Use of Neuro-2a Neuroblastoma Cells Versus Intact Neurons in Primary Culture for Neurotoxicity Studies 2005 ·PubMed ·Keith T. LePage, Robert Dickey, William H. Gerwick, Edward L.E. Jester, Thomas F. Murray	126
9	Neurotoxic Meroditerpenoids from the Tropical Marine Brown AlgaStypopodium flabelliforme 2005 ·Journal of Natural Products ·Omar M. Sabry, Simeon Andrews, Kerry L. McPhail, Douglas E. Goeger, Alex Yokochi, Keith T. LePage, Thomas F. Murray, William H. Gerwick	55
10	Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel 2002 ·Brain Research ·Keith T. LePage, Daniel G. Baden, Thomas F. Murray	28
11	Domoic acid neurotoxicity in cultured cerebellar granule neurons is controlled preferentially by the NMDA receptor Ca2+ influx pathway 2002 ·Brain Research ·Frederick W. Berman, Keith T. LePage, Thomas F. Murray	64
12	Nonmajor histocompatibility complex alloantigen effects on the fate of Rous sarcomas 2000 ·Poultry Science ·Keith T. LePage, W. Elwood Briles, (unknown), Robert L. Taylor	16
13	Rfp-Y genotype affects the fate of Rous sarcomas in B 2 B 5 chickens 2000 ·Immunogenetics ·Keith T. LePage, Marcia M. Miller, W. Elwood Briles, Robert L. Taylor	24
14	Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. 2000 ·PubMed ·(unknown), Marianna M. Newkirk, Carolyn Neville, Keith T. LePage, Paul R. Fortin	30
15	Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). 1998 ·PubMed ·(unknown), Keith T. LePage, Toshimitsu Niwa, Laurence A. Rubin	21
16	Antibody Response to Sheep Red Blood Cells in a Major Histocompatibility (B) Complex Aneuploid Line of Chickens 1996 ·Poultry Science ·Keith T. LePage, S.E. Bloom, (unknown)	24
17	Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta. 1995 ·Proceedings of the National Academy of Sciences ·Azeddine Atfi, Keith T. LePage, Pierre Allard, A. Chapdelaine, Simone Chevalier	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact